EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

AMPK‐Mediated Lipid Metabolic Reprogramming in Cancer: From Mechanisms to Targeted Therapies

Yuying Chen, Wen Liu iD, Bing Luo iD

Cell Biochemistry and Function · 2026

DOI: 10.1002/cbf.70314 ↗

At a glance

Übersichtsarbeit in Cell Biochemistry and Function, 2026. Written by Yuying Chen and 2 co-authors. Institution: Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, China. Major MEDLINE topics: AMP-Activated Protein Kinases, Neoplasms, Lipid Metabolism, Molecular Targeted Therapy. 127 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

AMP‐activated protein kinase (AMPK), a key regulator of cellular energy metabolism, is activated under conditions of energy stress to restore metabolic homeostasis by promoting catabolic pathways and inhibiting anabolic processes such as lipid synthesis. Multiple key molecules involved in lipid metabolism are regulated by AMPK, and its role in cancer progression through lipid metabolism is dual‐edged. On the one hand, AMPK suppresses lipogenesis by inhibiting key regulators such as SREBP, ACC, and HMGCR, thereby limiting the biosynthetic substrates and membrane lipid availability required for tumor cell proliferation. On the other hand, AMPK activation may also enhance fatty acid oxidation and metabolic adaptation, which can support growth and survival under nutrient limitation, hypoxia, or therapeutic stress. This dual role presents therapeutic challenges but also creates opportunities for context‐specific intervention. In this review, we summarize the mechanisms by which AMPK regulates lipid metabolism in cancer and discuss the current progress, therapeutic potential, and limitations of AMPK‐modulating strategies.

Subjects

MeSH terms (MEDLINE)

AMP-Activated Protein KinasesNeoplasmsLipid MetabolismMolecular Targeted TherapyHumansMetabolic ReprogrammingAnimals

Author keywords

AMPKcancerfatty acid oxidationlipid metabolismmetabolic reprogrammingtargeted therapy

Substances

AMP-Activated Protein Kinases

Authors and institutions

  • Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, China.

ORCID profiles: Wen Liu, Bing Luo

Funding

  • National Natural Science Foundation of China

Cite

APA

Chen, Y., Liu, W., & Luo, B. (2026). AMPK‐Mediated Lipid Metabolic Reprogramming in Cancer: From Mechanisms to Targeted Therapies. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70314

Vancouver

Chen Y, Liu W, Luo B. AMPK‐Mediated Lipid Metabolic Reprogramming in Cancer: From Mechanisms to Targeted Therapies. Cell Biochemistry and Function. 2026. doi:10.1002/cbf.70314

BibTeX
@article{Chen2026,
  author = {Chen, Yuying and Liu, Wen and Luo, Bing},
  title = {AMPK‐Mediated Lipid Metabolic Reprogramming in Cancer: From Mechanisms to Targeted Therapies},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  doi = {10.1002/cbf.70314}
}
Start for free →